FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308461283> ?p ?o ?g. }

• W4308461283 endingPage "385.e4" @default.
• W4308461283 startingPage "374" @default.
• W4308461283 abstract "Objective There is paucity of data on the durability of physician modified endografts (PMEGs) for complex abdominal (CAAAs) and thoracoabdominal aortic aneurysms (TAAAs) despite widespread use. The aim of this study was to evaluate and compare the early and long-term outcomes of fenestrated-branched endovascular aortic repair (FB-EVAR) for CAAAs and TAAAs using PMEGs. Methods We reviewed clinical data and outcomes of patients treated by FB-EVAR using PMEGs for CAAAs (defined as short-neck infrarenal, juxtarenal, and pararenal AAAs) and TAAAs between 2007 and 2019. All patients were treated by a dedicated team with extensive manufactured device experience. Endpoints included 30-day mortality and major adverse events, patient survival and freedom from aortic-related mortality (ARM), freedom from secondary intervention, target artery (TA) patency, and freedom from TA endoleak and TA instability. Results Of 645 patients undergoing FB-EVAR, 156 patients (24%) treated with PMEG (121 males; mean age, 75 ± 8 years) were included. There were 89 CAAAs, 33 extent IV TAAAs and 34 extent I to III TAAAs. A total of 452 renal-mesenteric targets (3.1 ± 1.0 vessels/patient) were incorporated. Patients with TAAAs had significantly (P < .05) larger aneurysms (73 ± 11 vs 68 ± 14 mm), more TAs incorporated (3.4 ± 0.9 vs 2.8 ± 1.0), and more often had previous aortic repair (54% vs 27%). Technical success was higher in patients treated for CAAAs (99% vs 91%; P = .04). Thirty-day and/or in-hospital mortality was 5.7% and was significantly lower for CAAAs compared with TAAAs (2% vs 10%; P = .04), with three of nine early mortalities (33%) among patients treated emergently. After a mean follow-up of 49 ± 38 months, there were 12 aortic-related deaths (7.6%), including nine early deaths (5.7%) from perioperative complications and three late deaths (1.9%) from rupture. At 5 years, patient survival was 41%. Patients treated for CAAAs had higher 5-year freedom from ARM (P = .016), TA instability (P = .05), TA endoleak (P = .01), and TA secondary interventions (P = .05) with a higher, but non-significant, freedom from sac enlargement ≥5 mm (P = .11). Primary and secondary TA patency was 91% ± 2% and 99% ± 1%, respectively. Sac regression ≥5 mm occurred in 67 patients (43%) and was associated with increased survival (hazard ratio, 0.54; 95% confidence interval, 0.37-0.80) compared with those without sac regression. Conclusions FB-EVAR using PMEGs was performed with acceptable long-term outcomes. Overall patient survival was low due to significant underlying comorbidities. Patients treated for CAAAs had higher freedom from ARM, TA instability, TA endoleak, TA secondary interventions, and a trend towards higher freedom from sac enlargement compared with patients treated for TAAAs. Sac regression was associated with improved patient survival." @default.
• W4308461283 created "2022-11-12" @default.
• W4308461283 creator A5028429089 @default.
• W4308461283 creator A5037244715 @default.
• W4308461283 creator A5039253984 @default.
• W4308461283 creator A5043875322 @default.
• W4308461283 creator A5044828024 @default.
• W4308461283 creator A5065997886 @default.
• W4308461283 date "2023-02-01" @default.
• W4308461283 modified "2023-10-02" @default.
• W4308461283 title "Five-year outcomes of physician-modified endografts for repair of complex abdominal and thoracoabdominal aortic aneurysms" @default.
• W4308461283 cites W1967008976 @default.
• W4308461283 cites W1968022698 @default.
• W4308461283 cites W1985036271 @default.
• W4308461283 cites W2010545357 @default.
• W4308461283 cites W2025319349 @default.
• W4308461283 cites W2030493815 @default.
• W4308461283 cites W2043576467 @default.
• W4308461283 cites W2082706795 @default.
• W4308461283 cites W2090368317 @default.
• W4308461283 cites W2108421432 @default.
• W4308461283 cites W2152614958 @default.
• W4308461283 cites W2214701701 @default.
• W4308461283 cites W2239834582 @default.
• W4308461283 cites W2325008173 @default.
• W4308461283 cites W2337929303 @default.
• W4308461283 cites W2408270188 @default.
• W4308461283 cites W2526728881 @default.
• W4308461283 cites W2616809217 @default.
• W4308461283 cites W2774941004 @default.
• W4308461283 cites W2793956033 @default.
• W4308461283 cites W2804341242 @default.
• W4308461283 cites W2811148571 @default.
• W4308461283 cites W2902826630 @default.
• W4308461283 cites W2906016167 @default.
• W4308461283 cites W2924296266 @default.
• W4308461283 cites W2969834225 @default.
• W4308461283 cites W2993524033 @default.
• W4308461283 cites W3012299676 @default.
• W4308461283 cites W3015528825 @default.
• W4308461283 cites W3037104672 @default.
• W4308461283 cites W3081539021 @default.
• W4308461283 cites W3161521270 @default.
• W4308461283 cites W3171980780 @default.
• W4308461283 cites W3173384188 @default.
• W4308461283 cites W3175957078 @default.
• W4308461283 cites W3210974876 @default.
• W4308461283 cites W3211652389 @default.
• W4308461283 cites W3211732177 @default.
• W4308461283 cites W4200463725 @default.
• W4308461283 cites W4212911831 @default.
• W4308461283 cites W4220743834 @default.
• W4308461283 cites W4224879674 @default.
• W4308461283 cites W4286252876 @default.
• W4308461283 doi "https://doi.org/10.1016/j.jvs.2022.09.019" @default.
• W4308461283 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36356675" @default.
• W4308461283 hasPublicationYear "2023" @default.
• W4308461283 type Work @default.
• W4308461283 citedByCount "7" @default.
• W4308461283 countsByYear W43084612832023 @default.
• W4308461283 crossrefType "journal-article" @default.
• W4308461283 hasAuthorship W4308461283A5028429089 @default.
• W4308461283 hasAuthorship W4308461283A5037244715 @default.
• W4308461283 hasAuthorship W4308461283A5039253984 @default.
• W4308461283 hasAuthorship W4308461283A5043875322 @default.
• W4308461283 hasAuthorship W4308461283A5044828024 @default.
• W4308461283 hasAuthorship W4308461283A5065997886 @default.
• W4308461283 hasConcept C126322002 @default.
• W4308461283 hasConcept C126838900 @default.
• W4308461283 hasConcept C141071460 @default.
• W4308461283 hasConcept C2776098176 @default.
• W4308461283 hasConcept C2776634560 @default.
• W4308461283 hasConcept C2777323849 @default.
• W4308461283 hasConcept C2780091579 @default.
• W4308461283 hasConcept C2780601773 @default.
• W4308461283 hasConcept C2781046184 @default.
• W4308461283 hasConcept C71924100 @default.
• W4308461283 hasConceptScore W4308461283C126322002 @default.
• W4308461283 hasConceptScore W4308461283C126838900 @default.
• W4308461283 hasConceptScore W4308461283C141071460 @default.
• W4308461283 hasConceptScore W4308461283C2776098176 @default.
• W4308461283 hasConceptScore W4308461283C2776634560 @default.
• W4308461283 hasConceptScore W4308461283C2777323849 @default.
• W4308461283 hasConceptScore W4308461283C2780091579 @default.
• W4308461283 hasConceptScore W4308461283C2780601773 @default.
• W4308461283 hasConceptScore W4308461283C2781046184 @default.
• W4308461283 hasConceptScore W4308461283C71924100 @default.
• W4308461283 hasFunder F4320332457 @default.
• W4308461283 hasFunder F4320334179 @default.
• W4308461283 hasIssue "2" @default.
• W4308461283 hasLocation W43084612831 @default.
• W4308461283 hasLocation W43084612832 @default.
• W4308461283 hasOpenAccess W4308461283 @default.
• W4308461283 hasPrimaryLocation W43084612831 @default.
• W4308461283 hasRelatedWork W1988626308 @default.
• W4308461283 hasRelatedWork W2016068315 @default.
• W4308461283 hasRelatedWork W2103984381 @default.
• W4308461283 hasRelatedWork W2170854937 @default.

• next